Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear transcription factor Y subunit beta is a component of the trimeric transcription factor NF-Y, which binds specifically to CCAAT box motifs in the promoters of a wide variety of genes. NFYB, along with subunits NF-YA and NF-YC, forms a highly conserved heterotrimer necessary for specific DNA binding and activation of target gene transcription. The subunit itself contains a histone-like motif and dimerizes with NF-YC before associating with NF-YA. NFYB has a central role in the regulation of gene expression related to cell cycle progression, endoplasmic reticulum stress, and DNA damage response, and it has been implicated in cancer development and chemotherapy resistance, particularly through pathways such as E2F1. The protein itself does not function as a therapeutic target of small molecule drugs or biologics as of current knowledge, but its activity and expression can influence cellular phenotypes relevant to drug resistance and disease progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear transcription factor Y subunit beta (NFYB).